Artificial Intelligence
New from the Proscia blog: Digital pathology has evolved far beyond improving quality and efficiency. It’s becoming a strategic gateway to business growth. This was the central message our CEO David West delivered during his breakout...
Optiscan and Mayo Clinic have combined to significantly advance the development of a digital confocal laser endomicroscopic imaging system for use in robotic surgery. Highlights Optiscan, in combination with the Mayo Clinic, has advanced...
Roche plans to invest as much as $550 million in its Indianapolis diagnostics campus during the next five years, with plans to build it into a U.S. manufacturing and distribution hub for its wearable diabetes blood sugar sensors. The announced...
As life sciences R&D teams increasingly leverage digital pathology and AI to accelerate their precision medicine programs, Proscia’s Concentriq LS platform is handling unprecedented volumes of high-resolution images, complex annotations,...
HERLEV, Denmark , May 8, 2025 /PRNewswire/ -- Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used with the ADAPT formula (age, diabetes status,...
ZEISS and Alpenglow Biosciences partner for co-development of 3D pathology solution Partnership to revolutionize clinical pathology with light sheet microscopy and AI analysis tailored for clinical applications Leveraging enhanced...
